Large and medium-sized pulmonary artery obstruction does not play a role of primary importance in the etiology of sickle-cell disease-associated pulmonary hypertension |
| |
Authors: | van Beers Eduard J,van Eck-Smit Berthe L F,Mac Gillavry Melvin R,van Tuijn Charlotte F J,van Esser Joost W J,Brandjes Dees P M,Kappers-Klunne Mies C,Duits Ashley J,Biemond Bart J,Schnog John-John B CURAMA Study Group |
| |
Affiliation: | Department of Hematology, Academic Medical Center, Amsterdam, the Netherlands. |
| |
Abstract: | BACKGROUND: Pulmonary hypertension (PHT) occurs in approximately 30% of adult patients with sickle-cell disease (SCD) and is a risk factor for early death. The potential role of pulmonary artery obstruction, whether due to emboli or in situ thrombosis, in the etiology of SCD-related PHT is unknown. METHODS: Consecutive SCD patients were screened for PHT (defined as a tricuspid regurgitant jet flow velocity > or = 2.5 m/s) employing echocardiography and were evaluated for pulmonary artery obstruction with ventilation-perfusion (VQ) scintigraphy. RESULTS: Fifty-three HbSS, 6 HbSbeta(0)-thalassemia, 20 HbSC, and 6 HbSbeta(+)-thalassemia patients were included. The overall prevalence of PHT was 41% in HbSS/HbSbeta(0)-thalassemia patients and 13% in HbSC/HbSbeta(+)-thalassemia patients. High-probability VQ defects (Prospective Investigation of Pulmonary Embolism Diagnosis criteria) were detected in two patients, one of whom had PHT. In HbSS/HbSbeta(0)-thalassemia patients with PHT, 19 patients (86%), 2 patients (9%), and 1 patient (5%) had low-, intermediate-, or high-probability scan results as compared to 30 patients (97%), 1 patient (3%), and 0 patients (0%) in HbSS/HbSbeta(0)-thalassemia patients without PHT (p = 0.31). In HbSC/HbSbeta(+)-thalassemia patients with PHT, 3 patients (100%), 0 patients (0%), and 0 patients (0%) had low-, intermediate-, and a high-probability scan as compared to 19 patients (90%), 1 patient (5%), and 1 patient (5%) in HbSC/HbSbeta(+)-thalassemia patients without PHT (p = 0.86). There were no statistical differences in irregular distribution of the radiopharmaceutical or nonspecific signs associated with PHT between patients with and without PHT. CONCLUSIONS: Although small pulmonary artery obstruction cannot be excluded, large to medium-sized pulmonary artery obstruction is an unlikely primary causative factor in SCD-related PHT. |
| |
Keywords: | echocardiography pulmonary artery obstruction pulmonary artery thrombosis pulmonary hypertension sickle-cell disease ventilation-perfusion scintigraphy IQR" },{" #name" :" keyword" ," $" :{" id" :" cekeyw180" }," $$" :[{" #name" :" text" ," _" :" interquartile range PHT" },{" #name" :" keyword" ," $" :{" id" :" cekeyw190" }," $$" :[{" #name" :" text" ," _" :" pulmonary hypertension PIOPED" },{" #name" :" keyword" ," $" :{" id" :" cekeyw200" }," $$" :[{" #name" :" text" ," _" :" Prospective Investigation of Pulmonary Embolism Diagnosis SCD" },{" #name" :" keyword" ," $" :{" id" :" cekeyw210" }," $$" :[{" #name" :" text" ," _" :" sickle-cell disease sPAP" },{" #name" :" keyword" ," $" :{" id" :" cekeyw220" }," $$" :[{" #name" :" text" ," _" :" systolic pulmonary artery pressure TRV" },{" #name" :" keyword" ," $" :{" id" :" cekeyw230" }," $$" :[{" #name" :" text" ," _" :" tricuspid regurgitant jet flow velocity VQ" },{" #name" :" keyword" ," $" :{" id" :" cekeyw240" }," $$" :[{" #name" :" text" ," _" :" ventilation-perfusion |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|